Inspire Medical Systems Q1 FY24: revenue $164.0M; diluted EPS −$0.34
- Form
- 10-Q
- Filed
- Period
- Importance
- Notable
- Accession
- 0001609550-24-000026
- Document
- 10-Q
- Exhibit 10.1
- Material contract
Key figures from this report
These are the numbers Inspire Medical Systems reported for Q1 FY24, the quarter ended Mar 31, 2024, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.
- Revenue$164.0MNo year-earlier figure tagged10-Q income statement, on EDGAR
- Net income−$10.0MNo year-earlier figure tagged10-Q income statement, on EDGAR
- Diluted EPS−$0.34No year-earlier figure tagged10-Q income statement, on EDGAR
- Cash and cash equivalents$175.4MNo year-earlier figure taggedCash and equivalents only; the company page adds short-term investments.10-Q balance sheet, on EDGAR
- Cash from operations$8.9MNo year-earlier figure tagged10-Q cash flow statement, on EDGAR
Similar companies
Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.
- Masimo MASI public float $3.9B, Jun 28, 2025
- Integer Holdings ITGR public float $4.3B, Jun 27, 2025
- TransMedics Group TMDX public float $4.4B, Jun 30, 2025
- Icu Medical ICUI public float $3.2B, Jun 30, 2025
- PROCEPT BioRobotics PRCT public float $3.2B, Jun 30, 2025